These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3819476)

  • 21. A method for studies of an El Tor-associated antigen of Vibrio cholerae O1.
    Svennerholm AM; Johnson G; Yan C
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):179-85. PubMed ID: 2060759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection afforded by anti-hemolysin against V. cholerae El Tor infection in experimental cholera.
    Chaicumpa W; Samrejrongroj P; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Jun; 11(2):294-301. PubMed ID: 7434081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
    Levinson KJ; Baranova DE; Mantis NJ
    Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of TnphoA mutants of Vibrio cholerae O139 for identification of antigens involved in colonisation.
    Bondre VP; Srivastava R; Sinha VB; Srivastava BS
    J Med Microbiol; 1997 Dec; 46(12):1007-11. PubMed ID: 9402922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholera outbreaks in the El Tor biotype era and the impact of the new El Tor variants.
    Mukhopadhyay AK; Takeda Y; Balakrish Nair G
    Curr Top Microbiol Immunol; 2014; 379():17-47. PubMed ID: 24710767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of a Vibrio cholerae 18-kDa antigen in vibrios.
    Sciortino CV
    FEMS Microbiol Lett; 1993 Jul; 111(1):49-55. PubMed ID: 8359680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response genes modulate serologic responses to Vibrio cholerae TcpA pilin peptides.
    Meeks MD; Wade TK; Taylor RK; Wade WF
    Infect Immun; 2001 Dec; 69(12):7687-94. PubMed ID: 11705949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,3-butanediol synthesis and the emergence of the Vibrio cholerae El Tor biotype.
    Yoon SS; Mekalanos JJ
    Infect Immun; 2006 Dec; 74(12):6547-56. PubMed ID: 17015461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TcpF is a soluble colonization factor and protective antigen secreted by El Tor and classical O1 and O139 Vibrio cholerae serogroups.
    Kirn TJ; Taylor RK
    Infect Immun; 2005 Aug; 73(8):4461-70. PubMed ID: 16040956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The characteristics of the protectiveness of a preparation of Vibrio cholerae outer membrane based on the data from a study using the ligated intestinal loop].
    Urbanovich LIa; Sappo SG; Kolesnik RS; Golubinskiĭ EP; Markov EIu; Ganin VS; Ivanova TA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):43-6. PubMed ID: 9245140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigens involved in resistance to mucosal association by Vibrio cholerae.
    Narendranathan R; Lutze LH; Jackson GD; Cooper GN
    J Med Microbiol; 1988 Feb; 25(2):129-38. PubMed ID: 3339633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophoretic mobility and immune response of outer membrane proteins of Vibrio cholerae O139.
    Pal S; Sasmal D; Guhathakurta B; Nair GB; Bhattacharya SK; Mallick R; Datta A
    FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):143-8. PubMed ID: 8880140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of Vibrio cholerae O1 classical biotype in 2012 in Iran.
    Bakhshi B; Boustanshenas M; Mahmoudi-aznaveh A
    Lett Appl Microbiol; 2014 Feb; 58(2):145-9. PubMed ID: 24117836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pili of vibrio cholerae widely distributed in serogroup O1 strains.
    Iwanaga M; Nakasone N; Yamashiro T; Higa N
    Microbiol Immunol; 1993; 37(1):23-8. PubMed ID: 8097272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic and Phenotypic Assays to Distinguish Vibrio cholerae Biotype.
    Brumfield KD; Carignan BM; Son MS
    Methods Mol Biol; 2018; 1839():11-28. PubMed ID: 30047050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The study of intestinal immunity against V. cholerae: purification of V. cholerae El Tor haemagglutinin and the protective role of its antibody in experimental cholera.
    Chaicumpa W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1979 Mar; 10(1):73-80. PubMed ID: 483020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a 20-kDa pilus protein expressed by a diarrheogenic strain of non-O1/non-O139 Vibrio cholerae.
    Sengupta TK; Nandy RK; Mukhopadhyay S; Hall RH; Sathyamoorthy V; Ghose AC
    FEMS Microbiol Lett; 1998 Mar; 160(2):183-9. PubMed ID: 9532736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Composition and immunochemical properties of the cell surface proteins of Vibrio cholerae.
    Kabir S
    J Gen Microbiol; 1986 Aug; 132(8):2235-42. PubMed ID: 3794649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.